Step Further Towards Targeted Senolytic Therapy:Therapeutic Potential of Upar-Car T Cells for Senescence-Related Diseases

Yujia Huang,Tao Liu

DOI: https://doi.org/10.1038/s41392-020-00268-7

IF: 39.3

2020-01-01

Signal Transduction and Targeted Therapy

Abstract:A very recent study published in Nature by Amor et al.1 identifies the urokinase-type plasminogen activator receptor(uPAR)as a broadly induced specific cell-surface marker during cell senescence,which could be used as a target for chimeric antigen receptor(CAR)T cell to specifically ablate senescent cells in vitro and in vivo.The authors intriguingly show that uPAR-specific CAR T-cell therapy improves the treatment outcome of lung adenocarcinomas and efficiently reduces liver fibrosis in mouse models,thus offering a promising novel therapeutic strategy for senescence-associated diseases(Fig.1).